Abstract
The title compound, C15H14Br2, obtained through the reduction of 4,4′-dibromochalcone, has monoclinic P21 symmetry at 100 K. No directional interactions could be identified in the crystal.
Funder
Defense Threat Reduction Agency (DTRA) - Joint Science and Technology Transfer Office for Chemical and Biological Defense
Air Force Office of Scientific Research
Publisher
International Union of Crystallography (IUCr)
Subject
Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation,General Medicine
Reference10 articles.
1. Bruker (2017). SADABS, APEX3 and SAINT. Bruker-Nonius AXS Inc., Madison, Wisconsin, USA.
2. WinGXandORTEP for Windows: an update
3. The Cambridge Structural Database
4. Mercury CSD 2.0– new features for the visualization and investigation of crystal structures
5. Murata, T., Umeda, M., Yoshikawa, S., Urbahns, K., Gupta, J. & Sakurai, O. (2004). Int. Patent WO 2004/043926 A1.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献